Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Jun 2016

Dong Tieying, Kang Xinmei, Liu Zhaoliang, Zhao Shu, Ma Wenjie, Xuan Qijia, Liu Hang, Wang Zhipeng, Zhang Qingyuan

Abstract excerpt

Glycometabolism is a distinctive aspect of energy metabolism in breast cancer, and key glycometabolism enzymes/pathways (glycolysis, hexosamine biosynthetic pathway, and pentose phosphate pathway) may directly or indirectly affect the clinical features. In this study, we analyzed the particular correlation between the altered glycometabolism and clinical features of breast cancer to instruct research and clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Glucosephosphate Dehydrogenase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoenzyme Techniques

Share to Neoadjuvant Therapy

Share to Neoplasm Staging

Share to Survival Rate

Share to Thyroid Hormones

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 26715276
DOI: 10.1007/s13277-015-4729-8

Genes

GFPT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.PMID 26715276Read ↗

Altered gene expression in glycolysis-cholesterol synthesis axis correlates with outcome of triple-negative breast cancer.Semantic proximity Read ↗

Expression of metabolism-related proteins in triple-negative breast cancer.Semantic proximity Read ↗

Breast cancer N Glycosylation dysregulation driven by mutations modulates chemotherapy response and macrophage immunosuppressionSemantic proximity Read ↗

Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancer.Semantic proximity Read ↗

Integrated Metabolic and Gene Expression Profiling Reveals New Therapeutic Modalities for Rapidly Proliferating Breast CancersSemantic proximity Read ↗

Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype.Semantic proximity Read ↗

Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes.Semantic proximity Read ↗

Prognosis and metabolism with a Golgi apparatus-related genes-based formula in breast cancer.Semantic proximity Read ↗

Proteogenomic Metabolism Dependent Signature Identifies Worse Outcome in Breast And Other CancersSemantic proximity Read ↗

Metabolic phenotypes in triple-negative breast cancer.Semantic proximity Read ↗

Expression of cell metabolism-related genes in different molecular subtypes of triple-negative breast cancer.Semantic proximity Read ↗

GPR81-mediated reprogramming of glucose metabolism contributes to the immune landscape in breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.